Towards a new chemotherapy for endometriosis: an experimentalist's perspective.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004715:Endometriosis / Q000188:drug therapy* / Q000209:etiology; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D010616:Phenanthrenes / Q000627:therapeutic use*; D011247:Pregnancy; D011372:Progestins / Q000627:therapeutic use*; D011555:Pseudopregnancy; D013738:Testolactone / Q000627:therapeutic use; D014770:Virilism / Q000517:prevention & control
D000970:Antineoplastic Agents; D004967:Estrogens; D007783:Lactones; D010616:Phenanthrenes; D011372:Progestins; D013738:Testolactone